FPH — Fisher & Paykel Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00
- NZ$13.82bn
- NZ$14.07bn
- NZ$1.58bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | NZAS | NZAS | NZAS | NZAS | NZAS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 8.3 | 4.1 | 1.5 | 2.1 | 2.8 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 253 | 321 | 625 | 324 | 238 |
Capital Expenditures | -133 | -171 | -185 | -170 | -211 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 7.6 | 15 | -203 | 80.3 | 200 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Cash from Investing Activities | -126 | -156 | -387 | -89.5 | -11.3 |
Financing Cash Flow Items | 1.8 | 2.3 | 3.5 | 3.2 | 3 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -113 | -159 | -188 | -236 | -197 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 15.1 | 5.5 | 49 | -0.8 | 32.2 |